Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000–2004)
- 1 December 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in Microbial Drug Resistance
- Vol. 12 (4) , 223-230
- https://doi.org/10.1089/mdr.2006.12.223
Abstract
Emergence and dissemination of Enterobacteriaceae isolates harboring carbapenemases in various geographic regions represents a significant threat to the management of nosocomial infections. Enterobacteriaceae isolates from the SENTRY Antimicrobial Surveillance Program (2000–2004) demonstrating decreased susceptibility to imipenem and meropenem (minimum inhibitory concentration [MIC], ≥2 mg/L) were evaluated for the production of metallo-β-lactamases and serine carbapenemases using disk approximation and polymerase chain reaction (PCR) tests. Carbapenemase-producing strains were epidemiologically typed by automated riboprinting and pulsed-field gel electrophoresis (PFGE) to establish clonality. Among 37,557 Enterobacteriaceae (5 genus groups) evaluated, 119 (0.32%) had increased carbapenem MIC values, and a carbapenemase was identified in 51 (42.9%) of these strains. KPC-2 and KPC-3 were the most frequently occurring carbapenemases (24 isolates, 20.2%) in the United States and were detected in Klebsiella spp, Citrobacter spp., Enterobacter spp., and Serratia marcescens strains isolated in New York, Arkansas, and Virginia. SME-2–producing S. marcescens were isolated in the New York City area, Texas, and Ohio, while NMC-A was found in one E. cloacae strain from New York. In contrast, metallo-β-lactamases were prevalent in Europe. IMP-1–producing E. cloacae (11 isolates) were detected in Turkey, while VIM-1–producing strains were found in Italy (Enterobacter spp.) and Greece (Klebsiella pneumoniae). Clonal dissemination of carbapenemase-producing strains was observed in several medical centers on both continents. The occurrence of carbapenemases in various Enterobacteriaceae remains rare but appears to be spreading geographically (not in Latin America), mainly with metallo-β-lactamases being found in Mediterranean Europe and KPC enzymes in the New York City area.Keywords
This publication has 35 references indexed in Scilit:
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- Emerging epidemic of metallo-β-lactamase–mediated resistancesDiagnostic Microbiology and Infectious Disease, 2005
- Carbapenemase-producingEnterobacteriaceae, U.S. RiversEmerging Infectious Diseases, 2005
- Dissemination and diversity of metallo-β-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance ProgramInternational Journal of Antimicrobial Agents, 2005
- The emergence and implications of metallo-β-lactamases in Gram-negative bacteriaClinical Microbiology & Infection, 2005
- Evaluation of the contemporary occurrence rates of metallo-β-lactamases in multidrug-resistant Gram-negative bacilli in Japan: Report from the SENTRY Antimicrobial Surveillance Program (1998–2002)Diagnostic Microbiology and Infectious Disease, 2004
- Emergence in Klebsiella pneumoniae and Enterobacter cloacae Clinical Isolates of the VIM-4 Metallo-β-Lactamase Encoded by a Conjugative PlasmidAntimicrobial Agents and Chemotherapy, 2004
- Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain ofKlebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f β-lactamase (SME-1) in the United States: results from the MYSTIC ProgrammeDiagnostic Microbiology and Infectious Disease, 2001